Rosiglitazone and other thiazolidinediones are thought to sensitize adipose and other tissues to insulin by activating a molecule called PPARγ. A recent study suggests that the therapeutic effect of rosiglitazone is mediated by its prevention of the phosphorylation of PPARγ.
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
潇洒的惋清
学术文献互助
cdercder
AllRightReserved
sanvva
GingerF
Scorpia112
HFH
尊嘟假嘟
OK
做实验的猫
小乐
贪玩的秋柔
互助
无极微光
Jobs
糊涂小子0629
arniu2008
张欢馨
皖公网安备34019202002308
